Verrica Pharmaceuticals

VRCA NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $3,826 $1,988 $2,917 $182
Gross Profit 2,688 1,607 2,772 46
EBITDA -18,259 -20,382 -23,917 -10,855
EBIT -18,599 -20,599 -24,270 -10,990
Net Income -20,331 -24,614 -24,802 -10,990
Net Change In Cash 3,826 1,988 2,917 182
Free Cash Flow -19,947 -14,958 -14,876 -4,728
Cash 48,939 69,547 84,308 55,140
Basic Shares 46,483 46,311 46,073 45,916

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $5,124 $9,032 $12,000 $12,000
Gross Profit 3,960 8,307 11,528 -229
EBITDA -62,386 -20,878 -30,785 -39,661
EBIT -63,222 -21,296 -30,908 -40,181
Net Income -66,995 -27,678 -38,903 -45,497
Net Change In Cash 5,124 9,032 12,000 12,000
Cost of Revenue 18,521 5,066 1,445
Free Cash Flow -38,939 -18,952 -28,465 -31,677
Cash 69,547 34,273 15,752 10,686
Basic Shares 45,342 34,163 27,044 24,995

Earnings Calls

Quarter EPS
2024-03-31 -$0.44
2023-12-31 -$0.53
2023-09-30 -$0.54
2023-06-30 -$0.24